Favorable Management of Repeated Serous Retinal Detachment with Continued Tumor Response in a Patient with Intrahepatic Cholangiocarcinoma during Treatment with Pemigatinib-Reference-Cited by-同舟云学术

Favorable Management of Repeated Serous Retinal Detachment with Continued Tumor Response in a Patient with Intrahepatic Cholangiocarcinoma during Treatment with Pemigatinib

Published:2023-04-15 Issue:8 Volume:62 Page:1151-1155
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yukutake Masanobu¹,Sekito Tsuyoshi¹,Yamakita Ichiko²,Itakura Hideki³,Kabu Koki⁴,Nagata Shinji¹

Affiliation:

1. Department of Gastroenterology, Hiroshima City Asa Citizens Hospital, Japan

2. Department of Cancer Genome & Clinical Oncology, Hiroshima City Asa Citizens Hospital, Japan

3. Itakura Eye Clinic, Japan

4. Medical Affairs, Incyte Biosciences Japan, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/8/62_0150-22/_pdf

Reference21 articles.

1. 1. Foundation for Promotion of Cancer Research. Cancer Statistics [Internet]. [cited 2022 Jun 14]. Available from: https://link.edgepilot.com/s/a4f5b12a/72fR6eLA20GBxKTb0GUbOg?u=https://ganjoho.jp/public/qa_links/report/statistics/pdf/cancer_statistics_2021.pdf

2. 2. Nagino M, Hirano S, Yoshitomi H, et al. Clinical practice guidelines for the management of biliary tract cancers 2019: the 3rd English edition. J Hepatobiliary Pancreat Sci 28: 26-54, 2021.

3. 3. Lee S, Oh SY, Kim BG, et al. Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer. Am J Clin Oncol 32: 348-352, 2009.

4. 4. Pino MS, Milella M, Gelibter A, et al. Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers. Oncology 76: 254-261, 2009.

5. 5. Sasaki T, Isayama H, Nakai Y, et al. Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine. Invest New Drugs 30: 708-713, 2012.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Subretinal Fluid Accumulation Induced by Futibatinib Therapy for Malignant Metastatic Breast Cancer;Ophthalmic Surgery, Lasers and Imaging Retina;2024-02

2. A drug safety evaluation of pemigatinib for advanced cholangiocarcinoma;Expert Opinion on Drug Safety;2023-06-26

3. Antineoplastics;Reactions Weekly;2023-05-13